Trial updateRetina
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Recruiting. Phase 3. Registered enrolment: 960. Merck Sharp & Dohme LLC
Why it matters
Track this study through NCT07705555. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 3
- Registered enrolment
- 960
- Results posted
- No
- Sponsor
- Merck Sharp & Dohme LLC
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.